Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' De Gramont, A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 23 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Maindrault-Goebel, F; de Gramont, A; Louvet, C; Andre, T; Carola, E; Mabro, M; Artru, P; Gilles, V; Lotz, JP; Izrael, V; Krulik, M
      High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

      EUROPEAN JOURNAL OF CANCER
    2. Louvet, C; Andre, T; Hammel, P; Selle, F; Landi, B; Cattan, S; Fonck, M; Flesch, M; Colin, P; Balosso, J; Ruszniewski, P; de Gramont, A
      Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM)

      ANNALS OF ONCOLOGY
    3. Kerrou, K; Montravers, F; Grahek, D; Younsi, N; Perniceni, T; Godeberge, P; Canuel, C; De Gramont, A; Talbot, JN
      [F-18]-FDG uptake in soft tissue dermatome prior to herpes zoster eruption: An unusual pitfall

      ANNALS OF NUCLEAR MEDICINE
    4. Vedrine, L; Artru, P; Tournigand, C; Louvet, C; De Gramont, A; Kruuk, M
      Carcinomatous meningitis in gastric cancer

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    5. Artru, P; Tournigand, C; Mabro, M; Lucchi, E; Louvet, C; De Gramont, A; Krulik, M
      Primary hyperparathyroidism associated with colon cancer

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    6. Andre, T; Colin, P; Louvet, C; Gamelin, E; Bouche, O; Achille, E; Colbert, N; Boaziz, C; Piedbois, P; Tubiana-Mathieu, N; Boutan-Laroze, A; Flesch, M; Billiau, V; Buyse, M; de Gramont, A
      Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminarysafety results

      SEMINARS IN ONCOLOGY
    7. Tournigand, C; Louvet, C; Molitor, JL; Dehni, N; Lejeune, V; Sezeur, A; Pigne, A; Marpeau, L; Cady, J; de Gramont, A
      Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    8. Louvet, C; de Gramont, A; Tournigand, C; Artru, P; Maindrault-Goebel, F; Krulik, M
      Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma

      CANCER
    9. Andre, T; Louvet, C; Maindrault-Goebel, F; de Gramont, A
      Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer

      BULLETIN DU CANCER
    10. Bensmaine, MA; Marty, M; de Gramont, A; Brienza, S; Levi, F; Ducreux, M; Francois, E; Gamelin, E; Bleiberg, H; Cvitkovic, E
      Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) +/- folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

      BRITISH JOURNAL OF CANCER
    11. Bensmaine, MA; de Gramont, A; Brienza, S; Marty, M; Levi, F; Ducreux, M; Francois, E; Gamelin, E; Bleiberg, H; Bleuzen, P; Simon, J; Cvitkovic, E
      Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/- folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients

      EUROPEAN JOURNAL OF CANCER
    12. Louvet, C; Coudray, AM; Tournigand, C; Prevost, S; Raymond, E; de Gramont, A; Chazard, M; Gespach, C
      Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice

      ANTI-CANCER DRUGS
    13. Maindrault-Goebel, F; de Gramont, A; Louvet, C; Andre, T; Carola, E; Gilles, V; Lotz, JP; Tournigand, C; Mabro, M; Molitor, JL; Artru, P; Izrael, V; Krulik, M
      Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer

      ANNALS OF ONCOLOGY
    14. de Gramont, A; Figer, A; Seymour, M; Homerin, M; Hmissi, A; Cassidy, J; Boni, C; Cortes-Funes, H; Cervantes, A; Freyer, G; Papamichael, D; Le Bail, N; Louvet, C; Hendler, D; de Braud, F; Wilson, C; Morvan, F; Bonetti, A
      Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

      JOURNAL OF CLINICAL ONCOLOGY
    15. Andre, T; Balosso, J; Louvet, C; Hannoun, L; Houry, S; Huguier, M; Colonna, M; Lotz, JP; De Gramont, A; Bellaiche, A; Parc, R; Touboul, E; Izrael, V
      Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: Results of a feasibility study

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    16. Mabro, M; de Gramont, A
      Aspirin against cancer.

      REVUE DE MEDECINE INTERNE
    17. Morel, P; Monconduit, M; Jacomy, D; Lenain, P; Grosbois, B; Bateli, C; Facon, T; Dervite, I; Bauters, F; Najman, A; de Gramont, A; Wattel, E
      Prognostic factors in Waldenstrom macroglobulinemia: a report on 232 patients with the description of a new scoring system and its validation on 253 other patients

      BLOOD
    18. Maindrault-Goebel, F; Louvet, C; Andre, T; Carola, E; Lotz, JP; Molitor, JL; Garcia, ML; Gilles-Amar, V; Izrael, V; Krulik, M; de Gramont, A
      Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

      EUROPEAN JOURNAL OF CANCER
    19. Andre, T; Louvet, C; Maindrault-Goebel, F; Couteau, C; Mabro, M; Lotz, JP; Gilles-Amar, V; Krulik, M; Carola, E; Izrael, V; de Gramont, A
      CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    20. Andre, T; Bensmaine, MA; Louvet, C; Francois, E; Lucas, V; Desseigne, F; Beerblock, K; Bouche, O; Carola, E; Merrouche, Y; Morvan, F; Dupon-Andre, G; de Gramont, A
      Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracilinfusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen

      JOURNAL OF CLINICAL ONCOLOGY
    21. Sezeur, A; De Gramont, A; Touboul, E; Beaugerie, L; Gallot, D; Cattan, S; Betton, PO; Carbonnel, F; Martel, P; Tarlat, E; Louvet, C; Cosnes, J; Housset, M; Malafosse, M
      Contribution of the telemedicine applied to digestive cancerology.

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    22. Mabro, M; Gilles-Amar, V; Louvet, C; Carola, E; Maindrault-Goebel, F; de Gramont, A; Krulik, M
      Bimonthly fluorouracil in elderly patients with metastatic colorectal cancer: a report of 50 patients.

      REVUE DE MEDECINE INTERNE
    23. Andre, T; Louvet, C; Raymond, E; Tournigand, C; de Gramont, A
      Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen

      ANNALS OF ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 02:33:07